The NHS will now offer immunotherapy pill Acarizax so the body can become less sensitive to dust mites over time and halt ...

The treatment is recommended for people aged 12 to 65 who have moderate to severe and persistent allergic rhinitis and have been diagnosed through clinical history and a positive test of their house ...

Thousands of people with a severe dust mite allergy could benefit from a "life changing" new daily treatment. The National ...

The National Institute for Health and Care Excellence (Nice) has given the green light to 12 SQ-HDM SLIT, also known as ...

People in England with a severe dust mite allergy are set to be offered a daily pill on the NHS, it has been announced today (Thursday January 30), as part of a big shake up.

A new treatment for severe dust mite allergy has been recommended by NICE, for patients whose symptoms have not been helped ...

GSK (GSK) announced that the European Medicines Agency, EMA, has accepted for review the Marketing Authorisation Application, MAA, for the use of depemokimab in two indications. The submitted indicati ...

GSK announces depemokimab applications accepted for review in China and Japan for asthma with type 2 inflammation and CRSwNP: London, UK Wednesday, January 29, 2025, 17:00 Hrs [IS ...

The growing demand for fast and effective sinusitis treatments is expected to drive further innovations in pharmaceuticals and medical devices. Increasing awareness, advancements in drug formulations ...